Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Jupiter Neurosciences, Inc. (JUNS) had Consolidated Net Income/Loss of $-1.53M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.53M |
|
-- |
|
-- |
|
$1.54M |
|
$-1.54M |
|
$0.01M |
|
$-1.53M |
|
$-1.53M |
|
$-1.53M |
|
$-1.53M |
|
|
Consolidated Net Income/Loss |
$-1.53M |
$-1.53M |
|
$-1.54M |
|
$-1.54M |
|
33.10M |
|
33.10M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$3.61M |
|
-- |
|
$1.35M |
|
$4.96M |
|
$1.89M |
|
-- |
|
$0.01M |
|
$1.90M |
|
$3.06M |
|
$3.06M |
|
$3.06M |
|
33.10M |
|
| Cash Flow Statement Financials | |
$-1.06M |
|
-- |
|
-- |
|
$3.77M |
|
$2.71M |
|
$-1.06M |
|
$0.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.91 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-49.89% |
|
-49.89% |
|
-30.81% |
|
-49.89% |
|
$0.09 |
|
$-0.03 |
|
$-0.03 |
|